2026-02-24
Exercise Recovery in Aging: Why Recovery Slows and Evidence-Based Strategies
Recovery from exercise slows significantly with age, affecting how often and how hard older adults can train. This review covers the biological reasons for prolonged recovery, its consequences for muscle preservation, and evidence-based strategies to support faster, more complete recovery.
2026-02-24
Vision and Age-Related Macular Degeneration: Lutein, Zeaxanthin, and AREDS2 Evidence
The AREDS2 trial established lutein and zeaxanthin as replacements for beta-carotene in the AMD supplement formula, reducing progression risk by 25% in high-risk eyes. Dietary intake from dark leafy greens provides equivalent carotenoids. This article explains what the evidence supports and what it does not.
2026-02-20
Chronic Stress Overload: Evidence for Theanine, Ashwagandha, Magnesium, and Phosphatidylserine
In chronic stress overload, sleep regularity and behavioral skills remain foundational. Theanine, ashwagandha, magnesium glycinate, and phosphatidylserine can provide modest adjunctive support.
2026-02-19
Apigenin and Sleep: Evidence, Mechanisms, and Protocol
Apigenin is being studied for sleep support through GABA-related pathways, with early human data suggesting possible modest benefits and a generally favorable short-term tolerability profile.
2026-02-09
Apigenin: CD38 Inhibition, NAD+ Preservation, and Sleep Evidence
Apigenin inhibits CD38, an enzyme that consumes NAD+ — positioning it as an indirect NAD booster. It also has mild sleep-promoting and senolytic properties. Human evidence is limited but mechanistic rationale is solid.